Head, Market Access

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. With purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives. Develop and own the U.S. market access strategy for Orca-T, ensuring alignment across pricing, reimbursement, distribution, and health economics. Serve as a core partner to Clinical, Medical Affairs, HEOR, and Regulatory in shaping data generation to support access and value propositions. Define and drive payer evidence needs, value messages, and economic models tailored to transplant centers, integrated delivery networks, and commercial & government payers. Lead launch readiness planning for Orca-T with cross-functional alignment on access priorities. Directly lead and develop a team of leaders. Foster a culture of innovation, collaboration, and accountability within the Market Access function. Oversee access tactics including payer engagement, pathway positioning, buy-and-bill and HUB support models, benefit verification, and prior authorization strategies. Partner with trade and distribution to optimize site-of-care strategy and provider logistics for cell therapy delivery. Collaborate with Legal and Compliance to ensure all market access activities adhere to regulatory standards and company policies.